These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 7636869)

  • 21. Synthesis and pharmacological evaluation of thiopyran analogues of the dopamine D3 receptor-selective agonist (4aR,10bR)-(+)-trans-3,4,4a,10b-tetrahydro-4-n-propyl-2H,5H [1]b enzopyrano[4,3-b]-1,4-oxazin-9-ol (PD 128907).
    van Vliet LA; Rodenhuis N; Dijkstra D; Wikström H; Pugsley TA; Serpa KA; Meltzer LT; Heffner TG; Wise LD; Lajiness ME; Huff RM; Svensson K; Sundell S; Lundmark M
    J Med Chem; 2000 Jul; 43(15):2871-82. PubMed ID: 10956195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conformational analysis of D1 dopamine receptor agonists: pharmacophore assessment and receptor mapping.
    Mottola DM; Laiter S; Watts VJ; Tropsha A; Wyrick SD; Nichols DE; Mailman RB
    J Med Chem; 1996 Jan; 39(1):285-96. PubMed ID: 8568818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. D
    Mailman RB; Yang Y; Huang X
    Eur J Pharmacol; 2021 Feb; 892():173760. PubMed ID: 33279520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors.
    Wilcox RE; Tseng T; Brusniak MY; Ginsburg B; Pearlman RS; Teeter M; DuRand C; Starr S; Neve KA
    J Med Chem; 1998 Oct; 41(22):4385-99. PubMed ID: 9784114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopamine D1 receptors: efficacy of full (dihydrexidine) vs. partial (SKF38393) agonists in primates vs. rodents.
    Watts VJ; Lawler CP; Gilmore JH; Southerland SB; Nichols DE; Mailman RB
    Eur J Pharmacol; 1993 Sep; 242(2):165-72. PubMed ID: 7902811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased sensitivity in the interaction of the dopaminergic/adenosinergic system at the level of the adenylate cyclase activity in the striatum of the "weaver" mouse.
    K B; V T; N P; M M; N M; F A
    Neurochem Int; 2016 Oct; 99():233-238. PubMed ID: 27498335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. trans-2,6-,3,6- and 4,6-diaza-5,6,6a,7,8,12b-hexahydro-benzo[c]phenanthrene-10,11- diols as dopamine agonists.
    Gu YG; Bayburt EK; Michaelides MR; Lin CW; Shiosaki K
    Bioorg Med Chem Lett; 1999 May; 9(10):1341-6. PubMed ID: 10360732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 8,9-dihydroxy-1,2,3,11b-tetrahydrochromeno[4,3,2,-de]isoquinoline (dinoxyline), a high affinity and potent agonist at all dopamine receptor isoforms.
    Grubbs RA; Lewis MM; Owens-Vance C; Gay EA; Jassen AK; Mailman RB; Nichols DE
    Bioorg Med Chem; 2004 Mar; 12(6):1403-12. PubMed ID: 15018913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional selectivity of dopamine receptor agonists. II. Actions of dihydrexidine in D2L receptor-transfected MN9D cells and pituitary lactotrophs.
    Kilts JD; Connery HS; Arrington EG; Lewis MM; Lawler CP; Oxford GS; O'Malley KL; Todd RD; Blake BL; Nichols DE; Mailman RB
    J Pharmacol Exp Ther; 2002 Jun; 301(3):1179-89. PubMed ID: 12023553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. (+/-)-3-[4'-(N,N-dimethylamino)cinnamyl]benzazepine analogs: novel dopamine D1 receptor antagonists.
    Shah JH; Kline RH; Geter-Douglass B; Izenwasser S; Witkin JM; Newman AH
    J Med Chem; 1996 Aug; 39(17):3423-8. PubMed ID: 8765528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Behavioral effects in the rat of dihydrexidine, a high-potency, full-efficacy D1 dopamine receptor agonist.
    Darney KJ; Lewis MH; Brewster WK; Nichols DE; Mailman RB
    Neuropsychopharmacology; 1991 Nov; 5(3):187-95. PubMed ID: 1684499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced D1 affinity in a series of piperazine ring substituted 1-piperazino-3-arylindans with potential atypical antipsychotic activity.
    Bøgesø KP; Arnt J; Frederiksen K; Hansen HO; Hyttel J; Pedersen H
    J Med Chem; 1995 Oct; 38(22):4380-92. PubMed ID: 7473566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Substituted hexahydrobenzo[f]thieno[c]quinolines as dopamine D1-selective agonists: synthesis and biological evaluation in vitro and in vivo.
    Michaelides MR; Hong Y; DiDomenico S; Bayburt EK; Asin KE; Britton DR; Lin CW; Shiosaki K
    J Med Chem; 1997 May; 40(11):1585-99. PubMed ID: 9171869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The discriminative properties of the D1 dopamine agonist dihydrexidine in the rat.
    Schechter MD
    Psychopharmacology (Berl); 1995 May; 119(1):79-84. PubMed ID: 7675953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluorescent and biotin probes for dopamine receptors: D1 and D2 receptor affinity and selectivity.
    Madras BK; Canfield DR; Pfaelzer C; Vittimberga FJ; Difiglia M; Aronin N; Bakthavachalam V; Baindur N; Neumeyer JL
    Mol Pharmacol; 1990 Jun; 37(6):833-9. PubMed ID: 2141665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dihydrexidine, a novel selective high potency full dopamine D-1 receptor agonist.
    Lovenberg TW; Brewster WK; Mottola DM; Lee RC; Riggs RM; Nichols DE; Lewis MH; Mailman RB
    Eur J Pharmacol; 1989 Jul; 166(1):111-3. PubMed ID: 2572425
    [No Abstract]   [Full Text] [Related]  

  • 37. Multiple fluorescent ligands for dopamine receptors. I. Pharmacological characterization and receptor selectivity.
    Barton AC; Kang HC; Rinaudo MS; Monsma FJ; Stewart-Fram RM; Macinko JA; Haugland RP; Ariano MA; Sibley DR
    Brain Res; 1991 May; 547(2):199-207. PubMed ID: 1679366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Probing the steric space at the floor of the D1 dopamine receptor orthosteric binding domain: 7α-, 7β-, 8α-, and 8β-methyl substituted dihydrexidine analogues.
    Cueva JP; Gallardo-Godoy A; Juncosa JI; Vidi PA; Lill MA; Watts VJ; Nichols DE
    J Med Chem; 2011 Aug; 54(15):5508-21. PubMed ID: 21714510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively.
    Urwyler S; Markstein R
    J Neurochem; 1986 Apr; 46(4):1058-67. PubMed ID: 2936868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dihydrexidine, a full D1 dopamine receptor agonist, induces rotational asymmetry in hemiparkinsonian monkeys.
    Johnson BJ; Peacock V; Schneider JS
    Pharmacol Biochem Behav; 1995 Aug; 51(4):617-22. PubMed ID: 7675833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.